Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells
Laura Codarri Deak, Valeria Nicolini, Masao Hashimoto, Maria Karagianni, Petra Schwalie, Laura Lauener, Eleni Maria Varypataki, Marine Richard, Esther Bommer, Johannes Sam, Stefanie Joller, Mario Perro, Floriana Cremasco, Leo Kunz, Emilio Yángüez, Tamara Hüsser, Ramona Schlenker, Marisa Mariani, Vinko Toševski, Sylvia Herter, Marina Bacac, Inja Waldhauer, Sara Colombetti, Xavier Guéripel, Stephan Wullschleger, Mélanie Tichet, Douglas Hanahan, Haydn Kissick, Stéphane Leclair, Anne Freimoser–Grundschober, Stefan Seeber, Volker Teichgräber, Rafi Ahmed, Christian Klein, Pablo Umaña (2022). PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells. , 610(7930), DOI: https://doi.org/10.1038/s41586-022-05192-0.
Article75 days agoAbstract 71: The immunocytokine PD1-IL2v overcomes immune checkpoint resistance, and combination with an anti-PD-L1 antibody further enhances its anti-tumor activity
Stephan Wullschleger, Mélanie Tichet, Laura Codarri Deak, Pablo Umaña, Christian Klein, Douglas Hanahan (2021). Abstract 71: The immunocytokine PD1-IL2v overcomes immune checkpoint resistance, and combination with an anti-PD-L1 antibody further enhances its anti-tumor activity. , 81(13_Supplement), DOI: https://doi.org/10.1158/1538-7445.am2021-71.
Article75 days agoBispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages
Mélanie Tichet, Stephan Wullschleger, Agnieszka Chryplewicz, Nadine Fournier, Rachel Marcone, Annamaria Kauzlaric, Krisztián Homicskó, Laura Codarri Deak, Pablo Umaña, Christian Klein, Douglas Hanahan (2023). Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages. , 56(1), DOI: https://doi.org/10.1016/j.immuni.2022.12.006.
Article75 days ago